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Aldrich. Fluorescein-labeled Maackia amurensis leukoagglutinin was provided by Vector Laboratories.
Trypanosoma cruzi trans-sialidase (TcTS) was subcloned by S. Kaloo (University of Manchester) in E.
coli. DMPC and DPPC were supplied by Avanti Polar Lipids. Other reagents were purchased from Sigma-Aldrich and used as received unless otherwise stated.
2- ((2,2,3,3,4,4,5,5,6,6,7,7,8,8,9 ,9-Hexadecafluoro-10-(pyren-1-ylmethoxy)decyl)oxy-N-(2-(2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl-(1'-4')-2'',3'',6''-tri-O-acetyl-β-Dglucopyranosyl)oxyethyl))acetamide (8). 2, 2, 3, 3, 4, 4, 5, 5, 6, 6, 7, 7, 8, 8, 9 ,9-Hexadecafluoro-10-(pyren-1-ylmethoxy)-decyloxy)-acetic acid (6, 1 eq.), dicyclohexylcarbodiimide (DCC, 1.3 eq.) and Nhydroxysuccinimide (NHS, 1.3 eq.) were dissolved in dry CH2Cl2 under N2. The solution was left to stir for 3 h at room temperature, after which time a milky white precipitate had formed. The reaction mixture was filtered through cotton wool to remove the precipitate and 2,3,4,6-tetra-O-acetyl-β-Dgalactopyranosyl(1-4)-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-1-(2-hydroxyethyl)amine 7 (1.5 eq.) was added in dry CH2Cl2 (1 mL). The mixture was stirred under N2 overnight. The mixture was filtered again and the solvent was evaporated under reduced pressure. The crude mixture was then purified using two rounds of flash column chromatography (first 19:1 CHCl3/MeOH on silica, then 3:2:1 ethyl acetate/CHCl3/cyclohexane on silica followed by MeOH flush to recover the product 69.3, 70.9, 71.1, 71.7, 72.0, 72.9, 73.0, 73.2, 76.4, 100.6, 101.2, 123.2, 124.6, 124.7, 125.1, 125.6 (2 × CH), 126.3, 127.4 (2 × CH), 128.0, 128.3, 129.3, 129.7, 130.9, 131.3, 132.0, 168.2, .3 (7 × CO) (CF2 signals are weak complex multiplets); IR υ (cm -1 ) 1020 , 1263 , 1577 , 1610 , 2933 2, 3, 3, 4, 4, 5, 5, 6, 6, 7, 7, 8, 8, 9 ,9-Hexadecafluoro-10-(pyren-1-ylmethoxy)decyl)oxy-N-(2-(2',3',4',6'- 68.5, 69.2, 71.6, 71.7, 72.6, 74.2, 74.4, 75.8 (2 × CH), 76.5, 81.5, 103.8, 104.9, 123.8, 124.6, 124.9, 125.1, 125.9 (2 × CH), 126.7, 127.8, 127.9, 128.1, 128.3, 129.7, 130.9, 131.1, 131.6, 131.9, 168.9 were formed by extrusion (19 times) through an 800 nm pore polycarbonate membrane, above the Tm, using an Avestin Liposofast extrusion apparatus.
General reaction procedure: Vesicle suspension containing 1 at 1 or ~9% mol/mol loading (100 μL, ~180 μM 1 in 100 mM phosphate buffer, pH 7.4 at 37 °C), TcTS solution (1 or 5 μL, 3.91 μM, 100 mM phosphate buffer, pH 7.4 at 37 °C) and fetuin (1 mg or 5 mg, equivalent to 1.25 mM and 6 mM sialic acid respectively S6 ) were mixed in a 200 μL Eppendorf tube or small volume mass spectrometry vial and incubated at 37 °C. The enzyme concentration was estimated using its UV absorption at 280 nm; S7 the molar extinction coefficient was estimated at ε = 147,250 Lmol -1 cm -1 from the tryptophan and tyrosine residues in the protein amino acid sequence. S8
MALDI-ToF/ToF analysis: Samples were prepared as for β4GalT1 analysis, S9 but MALDI-ToF spectra were taken in both reflector-positive and linear-positive modes.
S6
Reaction rate determination -HPLC: Enzymatic reactions were performed as outlined in the general TcTS reaction procedure and were analyzed using a similar HPLC procedure used for β4GalT1
analysis. S9 Doped vesicles (~9% mol/mol 1 in the appropriate matrix, 100 μL, 2.0 mM total lipid in phosphate buffer pH 7.4 at 37 °C), sialic acid donor (fetuin, 5 mg, or MuNANA, 5.8 μL of 0.1 M) and TcTS (5 μL, ~3.9 μM in phosphate buffer pH 7.4 at 37 °C) were added to a mass spectrometry vial with a reduced volume insert. The analytical HPLC was programmed to inject 5 μL aliquots from the vial onto the column every 30 minutes for 7 h. The experiments were run using reverse phase solvent system conditions (50:50 acetonitrile/ water (+ 0.1% formic acid)). Percent conversions were determined using the ratio of product peak area to the combined product and starting material area. GUV preparation: Two heated ITO coated slides were evenly coated with DMPC (18 μL, 10 mM) and glycolipid (22 μL, 0.9 mM) from stock solutions of known concentration in CHCl3. The slides were dried under vacuum for 1 h to give a thin lipid film. A rubber spacer was carefully placed on top of each slide, and a second ITO slide to form a chamber. The chambers were secured with binder clips and fitted with short strips of copper tape at the top corners of the chamber. The chambers were filled with glucose solution (550-600 μL, 300 mOsm) and sealed using modelling clay. The copper strips were connected to electrodes, and vesicles were electroformed at 30 °C. After electroformation, GUVs were mixed with sucrose solution (200 μL, 300 mOsm) and visualized by epi-fluorescence microscopy in custom-made chambers.
S7
S.2. Spectra of novel compounds 2- ((2,2,3,3,4,4,5,5,6,6,7,7,8,8,9 ,9-Hexadecafluoro-10-(pyren-1-ylmethoxy)decyl)oxy-N-(2-
Figure S.1. 1 H and 13 C NMR in CDCl3 of 2- ((2,2,3,3,4,4,5,5,6,6,7,7,8,8,9 ,9-Hexadecafluoro-10-(pyren-1- 2, 3, 3, 4, 4, 5, 5, 6, 6, 7, 7, 8, 8 C NMR in DMF-d7 of 2- ((2,2,3,3,4,4,5,5,6,6,7,7,8,8,9 ,9-Hexadecafluoro-10-(pyren-1- a flow rate of 0.8 mL/min. The HPLC DAD module was set to detect the pyrenyl UV-visible absorption at 346 nm. This was repeated every half hour for 8 hours and at 24 hours. Percent conversions were determined using the ratio of product peak area to the combined product and starting material area.
The best wavelength to monitor the conversion of 1 to 2 by HPLC was the strong pyrene absorption at 346 nm. The extinction co-efficient for lipid 1 at 346 nm in 1:1 CHCl3:MeOH is (2.9 ± 0.2) × 10 4 M -1 cm -1 , and the product lipid 2 will have a very similar extinction co-efficient (e.g. GlcNAc capped
analogue lipid 3 has ε = (3.6 ± 0.3) × 10 4 M -1 cm -1 and a galactose capped analogue lipid 3 has ε = (3.9 ± 0.3) × 10 4 M -1 cm -1 ). The reaction progress was monitored by HPLC, injects (5 µL, with a 10 µL CH3OH needle wash) were performed on a 30 minute gradient 50:50 CH3CN (+0.1% TFA)/H2O (+0.1% TFA) to 80% CH3CN (+0.1%) with a 0.8 mL/min flow rate on a Phenomenex Luna C18 column fitted with a guard column.
The HPLC DAD module was again set to detect the pyrenyl UV-visible absorption at 346 nm, percent conversions calculated from the peak area ratio of product to starting material. Fluorescence spectroscopy was used to monitor the release of methylumbelliferone product emission at 450 nm. 
